Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
NCT06423781
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
233
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
BHV-7000
Sponsor
Biohaven Therapeutics Ltd.